Examkin

Question

Difficulty: HardCardiovascular System

A 5454-year-old man is brought to the emergency department via ambulance after his wife found him lethargic at home. She reports that he has a medical history of hypertension, major depressive disorder, and hyperlipidemia. Empty bottles of metoprolol and hydrochlorothiazide were found near his bed. On arrival, the patient is minimally responsive. His temperature is 36.5∘C36.5^\circ\text{C} (97.7∘F97.7^\circ\text{F}), blood pressure is 70/4070/40 mmHg, pulse is 3434/min, and respiratory rate is 1414/min. The 1212-lead electrocardiogram demonstrates sinus bradycardia with a first-degree atrioventricular block and no acute ST-segment changes. Intravenous access is established, and a 11-liter bolus of normal saline is rapidly infused with no improvement in hemodynamics.

Arrange the following subsequent interventions in the most appropriate chronological sequence for the emergency management of this patient's condition.

  1. 1Administer an initial trial of intravenous atropine to attempt vagolysis.
  2. 2Administer an intravenous bolus of glucagon to stimulate myocardial adenylate cyclase.
  3. 3Initiate high-dose insulin-euglycemia therapy to improve myocardial contractility.
  4. 4Evaluate for and initiate transvenous cardiac pacing or mechanical circulatory support.

Answer

The correct sequence is: 1) Administer an initial trial of intravenous atropine, 2) Administer an intravenous bolus of glucagon, 3) Initiate high-dose insulin-euglycemia therapy, 4) Evaluate for and initiate transvenous cardiac pacing or mechanical circulatory support.
The optimal sequence for managing hemodynamically unstable bradycardia secondary to beta-blocker toxicity requires stepwise escalation. First, an initial trial of intravenous atropine is administered, as it is the standard first-line treatment for any unstable bradycardia and is immediately available. Because atropine often fails to overcome severe beta-blockade, the immediate next step is an intravenous bolus of glucagon. Glucagon is the specific first-line antidote; it bypasses the blocked beta-receptors and directly stimulates adenylate cyclase to increase cyclic AMP, thereby improving chronotropy and inotropy. If cardiogenic shock persists, the third step is the initiation of high-dose insulin-euglycemia therapy (HDI). HDI is a highly effective inotrope that shifts myocardial metabolism toward carbohydrate utilization, though it requires time to prepare and take effect. Finally, if the patient remains refractory to all pharmacologic measures, invasive salvage therapies such as transvenous cardiac pacing or extracorporeal membrane oxygenation (ECMO) must be initiated. Electrical pacing is reserved for the final step because the profoundly depressed myocardium frequently fails to achieve mechanical capture.

Step-by-Step Solution

1
Identify the underlying toxidrome and the patient's hemodynamic instability.
The patient is diagnosed with severe symptomatic bradycardia and cardiogenic shock due to beta-blocker overdose.
The clinical presentation of profound bradycardia, hypotension, and empty metoprolol bottles points to life-threatening beta-blocker toxicity requiring immediate sequential intervention.
2
Follow standard resuscitation protocols for unstable bradycardia.
Intravenous atropine is given as the first-line agent.
Atropine is the universal initial pharmacologic treatment for unstable bradycardia because it is rapidly available, although it may ultimately be insufficient in severe beta-blocker toxicity.
3
Administer specific pharmacologic antidotes for the suspected ingestion.
Intravenous glucagon is administered as a rapid bolus.
Glucagon directly activates adenylate cyclase independent of the beta-adrenergic receptor, making it the fastest-acting specific antidote to restore myocardial contractility and heart rate.
4
Escalate to sustained metabolic support and prepare for invasive interventions.
High-dose insulin-euglycemia therapy is initiated, followed by transvenous pacing if shock persists.
High-dose insulin provides delayed but potent inotropic support. Invasive pacing is reserved for refractory cases because electrical capture is difficult to achieve in severely poisoned myocardium.

Key Concept

The stepwise management of beta-blocker toxicity progresses from standard bradycardia algorithms (atropine) to specific rapidly acting antidotes (glucagon), followed by sustained metabolic support (high-dose insulin), and finally escalates to invasive salvage therapies (transvenous pacing).

Alternative Method

In cases where glucagon is unavailable or only partially effective, early initiation of vasopressors (such as epinephrine or norepinephrine infusions) is often utilized concurrently with high-dose insulin therapy in clinical practice.
Estimated Time:1m 30s
Rate this question

Topics

Cardiovascular System

More questions from this topic